We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$536M
AUM Growth
+$12.7M
Cap. Flow
-$1.73M
Cap. Flow %
-0.32%
Top 10 Hldgs %
55.09%
Holding
62
New
3
Increased
27
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$5.14M
2
HSY icon
Hershey
HSY
+$2.45M
3
CTVA icon
Corteva
CTVA
+$2.27M
4
WBA
Walgreens Boots Alliance
WBA
+$775K
5
DOW icon
Dow Inc
DOW
+$552K

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$6.98M
2
CSCO icon
Cisco
CSCO
+$4.51M
3
VVV icon
Valvoline
VVV
+$2.33M
4
CHL
China Mobile Limited
CHL
+$1.16M
5
NVS icon
Novartis
NVS
+$789K

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 20.73%
3 Financials 14.14%
4 Industrials 12.91%
5 Consumer Staples 12.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHKP icon
26
Check Point Software Technologies
CHKP
$13.6B
$5.02M 0.94%
43,426
+424
+1% +$50.1K
BTI icon
27
British American Tobacco
BTI
$131B
$4.99M 0.93%
142,972
-587
-0.4% -$22.2K
KO icon
28
Coca-Cola
KO
$362B
$4.77M 0.89%
93,720
SABR icon
29
Sabre
SABR
$704M
$4.04M 0.75%
182,023
-1,059
-0.6% -$22.7K
TTE icon
30
TotalEnergies
TTE
$187B
$3.72M 0.69%
66,657
+56
+0.1% +$3.06K
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.48M 0.65%
16,323
SWK icon
32
Stanley Black & Decker
SWK
$14.6B
$3.44M 0.64%
23,818
+432
+2% +$60.9K
UL icon
33
Unilever
UL
$132B
$3.1M 0.58%
44,395
-1,381
-3% -$93.7K
NVO
34
Novo Nordisk
NVO
$220B
$3.08M 0.58%
120,792
-1,974
-2% -$48.8K
MDLZ icon
35
Mondelez International
MDLZ
$77.9B
$2.98M 0.56%
55,256
MRSH
36
Marsh
MRSH
$87.5B
$2.94M 0.55%
29,432
-253
-0.9% -$24.2K
DOX icon
37
Amdocs
DOX
$5.64B
$2.9M 0.54%
46,714
+1,085
+2% +$62.7K
SNY icon
38
Sanofi
SNY
$105B
$2.73M 0.51%
63,165
-1,361
-2% -$57.9K
CPRT icon
39
Copart
CPRT
$27.6B
$2.67M 0.5%
143,032
+1,156
+0.8% +$19.8K
CTVA icon
40
Corteva
CTVA
$58.6B
$2.49M 0.46%
+84,235
New +$2.27M
LIN icon
41
Linde
LIN
$234B
$2.4M 0.45%
11,953
+222
+2% +$41.5K
JCI icon
42
Johnson Controls International
JCI
$87.5B
$2.39M 0.45%
57,817
+2,407
+4% +$92.6K
HOG icon
43
Harley-Davidson
HOG
$2.61B
$2.33M 0.43%
64,911
+6,031
+10% +$219K
WMT icon
44
Walmart Inc
WMT
$889B
$2.2M 0.41%
59,850
KOF icon
45
Coca-Cola Femsa
KOF
$22.9B
$2.11M 0.39%
33,914
-815
-2% -$52.2K
BKR icon
46
Baker Hughes
BKR
$60.1B
$1.83M 0.34%
74,365
+1,020
+1% +$24.6K
TIF
47
DELISTED
Tiffany & Co.
TIF
$1.69M 0.32%
18,073
+162
+0.9% +$16.1K
BDX icon
48
Becton Dickinson
BDX
$43.8B
$1.59M 0.3%
6,458
KT icon
49
KT
KT
$8.92B
$1.39M 0.26%
112,397
-1,387
-1% -$16.9K
VIV icon
50
Telefônica Brasil
VIV
$22.5B
$1.22M 0.23%
94,008
-813
-0.9% -$9.87K

Similar funds

Foyston, Gordon, & Payne's Q2 2019 Portfolio in Review

As of Q2 2019, Foyston, Gordon, & Payne held 62 positions worth $536M, up 2.4% from $523M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Foyston, Gordon, & Payne's Q2 2019 filing shows 3 new, 27 increased, 21 reduced and 2 closed positions. Its largest new stake was Corteva: 84,235 shares worth $2.49M. The largest sale was PepsiCo, an estimated $6.98M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Foyston, Gordon, & Payne's largest Q2 2019 buy was Corteva: 84,235 shares worth $2.49M.
  • Foyston, Gordon, & Payne added most to DuPont de Nemours in Q2 2019, an estimated $5.14M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2019 reduction was PepsiCo, cutting an estimated $6.98M.
  • Foyston, Gordon, & Payne fully exited China Mobile Limited in Q2 2019, selling an estimated $1.16M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 55% of its $536M portfolio in Q2 2019.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 2 in Q2 2019.
  • Foyston, Gordon, & Payne's portfolio value rose 2.4% quarter-over-quarter to $536M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2019, filed 15 Aug 2019.